itchieabsolutely spot on! finally we are going to see fight to buy these shares.fundamentally the company is in great shape...this bloody side show has been distracting what resources CQT is sitting on.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling